Cheaper Alternatives to OatMeds: Seven GLP-1 Providers Compared

Last reviewed: September 18, 2026 Last updated: September 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

OatMeds charges $199/month for compounded semaglutide injection and $229/month for compounded tirzepatide injection on month-to-month billing (captured September 4, 2026; oatmeds.com). Prepaid 12-week plans drop the per-month equivalent—starter semaglutide runs $99/month equivalent ($297 upfront) and starter tirzepatide $133/month equivalent ($399 upfront)—but require full payment at enrollment and repeat every three months. Among seven alternatives verified at checkout between July 17 and July 23, 2026, PlexusDx delivers lower 12-month semaglutide costs than OatMeds' monthly plan ($2,268 month-to-month vs. $2,388) and matches or beats OatMeds' prepaid starter equivalent when you commit to six months ($1,788 vs. approximately $1,287 for OatMeds starter over 12 months, our calculation). For tirzepatide, OatMeds' prepaid plans undercut every alternative on a 12-month basis, but its monthly plan ($2,748/year) sits near the middle of the field. Eden, PlexusDx, and Peak Wellness all offer competitive tirzepatide rates without requiring quarterly upfront payments.

At-a-glance comparison: OatMeds vs. seven alternatives

All rates reflect ongoing, all-inclusive monthly billing and include medication, provider access, and shipping unless otherwise noted. Henry Meds offers tirzepatide only as an oral dissolving tablet; no monthly injection rate was captured.

OatMeds pricing: monthly billing and prepaid tiers

OatMeds offers compounded semaglutide and compounded tirzepatide injection with no additive, or semaglutide with B12 or glycine (captured September 4, 2026; oatmeds.com). The monthly plan bills every four weeks: $199/month for semaglutide (no additive) and $229/month for tirzepatide. Semaglutide with B12 or glycine is available at an introductory rate of $179/month on monthly billing; the standard ongoing rate for that formulation is $199/month.

Prepaid 12-week plans require full upfront payment and lower the per-month equivalent. The starter semaglutide plan (no additive) costs $297 total upfront—$99 per-month equivalent—and the standard semaglutide plan costs $399 upfront—$133 per-month equivalent. For tirzepatide, the starter plan is $399 upfront ($133/month equivalent) and the standard plan is $499 upfront ($166/month equivalent). Each 12-week cycle must be renewed with a new upfront payment. Over 12 months, four cycles of the starter semaglutide plan total approximately $1,287 (our calculation, prorating 48 weeks to 52); the monthly semaglutide plan totals $2,388.

No membership fee applies to any OatMeds plan.

Like-for-like monthly comparisons: semaglutide

On pure month-to-month billing, OatMeds' $199 semaglutide rate is competitive but not the lowest. PlexusDx charges $189/month with no commitment, Eden $198/month (all-in with membership), Peak Wellness $249/month, Found $289/month cash, Henry Meds $297/month, TrimRx $299/month (checkout-verified ongoing rate), and Embody $299/month (all captured July 17–23, 2026, except OatMeds September 4, 2026, and PlexusDx September 18, 2026).

Over 12 months at standard monthly rates (our calculation):

• PlexusDx month-to-month: $189 × 12 = $2,268
• Eden: $198 × 12 = $2,376
• OatMeds monthly: $199 × 12 = $2,388
• Peak Wellness: $249 × 12 = $2,988
• Found cash MTM: $289 × 12 = $3,468
• Henry Meds: $297 × 12 = $3,564
• Embody: $299 × 12 = $3,588
• TrimRx: $299 × 12 = $3,588

PlexusDx undercuts OatMeds' no-additive monthly plan by $10/month ($120/year).

Like-for-like prepaid comparisons: semaglutide

OatMeds' 12-week starter semaglutide plan ($99/month equivalent, $297 upfront) and standard plan ($133/month equivalent, $399 upfront) require comparing against other providers' multi-month commitments. PlexusDx offers three-month and six-month tiers that bill in full at enrollment.

Over 12 months (our calculation, annualizing the per-month rate or summing quarterly cycles):

• OatMeds starter (4 × $297 prepaid 12-week cycles): ≈ $1,287
• OatMeds standard (4 × $399 prepaid 12-week cycles): ≈ $1,729
• PlexusDx 6-month commitment: $149 × 12 = $1,788 ($894 billed every six months)
• PlexusDx 3-month commitment: $169 × 12 = $2,028 ($507 every three months)
• Found 12-month prepaid cash: from $169 × 12 = $2,028 (paid in full at enrollment)

OatMeds' starter plan delivers the lowest 12-month total among verified alternatives, but demands four separate $297 payments. PlexusDx's six-month plan requires two $894 payments and lands $501 higher over the year. PlexusDx's three-month plan matches Found's 12-month prepaid equivalent and exceeds OatMeds' starter by $741 over 12 months.

Like-for-like monthly comparisons: tirzepatide

OatMeds charges $229/month for compounded tirzepatide injection on monthly billing—lower than most alternatives but not the floor. Eden charges $298/month (all-in), PlexusDx $289/month month-to-month, Peak Wellness $349/month, Embody $349/month, Found $359/month cash MTM, and TrimRx $399/month checkout-verified (all captured July 17–23, 2026, except OatMeds September 4, 2026, and PlexusDx September 18, 2026).

Over 12 months at standard monthly rates (our calculation):

• OatMeds monthly: $229 × 12 = $2,748
• PlexusDx month-to-month: $289 × 12 = $3,468
• Eden: $298 × 12 = $3,576
• Peak Wellness: $349 × 12 = $4,188
• Embody: $349 × 12 = $4,188
• Found cash MTM: $359 × 12 = $4,308
• TrimRx: $399 × 12 = $4,788

OatMeds holds the lowest month-to-month tirzepatide rate among all verified providers, $60/month ($720/year) below PlexusDx and $69/month ($828/year) below Eden.

Like-for-like prepaid comparisons: tirzepatide

OatMeds' tirzepatide starter plan ($399 upfront, $133/month equivalent over 12 weeks) and standard plan ($499 upfront, $166/month equivalent) set benchmarks for prepaid tiers.

Over 12 months (our calculation):

• OatMeds starter (4 × $399): ≈ $1,729
• OatMeds standard (4 × $499): ≈ $2,154
• PlexusDx 6-month commitment: $249 × 12 = $2,988 ($1,494 every six months)
• PlexusDx 3-month commitment: $269 × 12 = $3,228 ($807 every three months)

OatMeds' prepaid tirzepatide plans deliver the lowest verified 12-month totals. Its starter plan undercuts PlexusDx's six-month tier by $1,259/year, though it requires four quarterly payments instead of two semiannual ones. Peak Wellness and other providers publish lower rates on six-month prepaid plans, but specific per-month equivalents were not captured at checkout.

Evidence conflicts: advertised vs. checkout rates

TrimRx advertises semaglutide at $199/month and tirzepatide at $349/month, but checkout billing verified ongoing rates of $299 semaglutide and $399 tirzepatide (captured July 17–23, 2026). The advertised figures may reflect introductory periods or require longer prepaid commitments; the higher rates apply to standard monthly billing. Found's widely advertised $99/month rate is an insurance-track, 12-month prepaid per-month equivalent, not a month-to-month charge; cash month-to-month plans start at $289 semaglutide and $359 tirzepatide. Confirm final pricing at checkout before enrolling.

Strengths and gaps by provider

OatMeds: Competitive month-to-month rates for both compounds; lowest tirzepatide MTM among verified alternatives; prepaid starter plans yield the lowest verified 12-month totals for both semaglutide and tirzepatide. Prepaid plans require full payment every 12 weeks with no option to spread cost across the quarter. Additive options (B12, glycine) available; semaglutide with B12 or glycine is offered at an introductory rate of $179/month with a standard ongoing rate of $199/month. No membership fee. Limited public review volume captured; verification links retained but insufficient data for thematic analysis.

PlexusDx: Month-to-month semaglutide ($189) beats OatMeds' no-additive monthly rate by $10/month. Six-month semaglutide commitment ($149/month, $1,788/year) sits $501 higher than OatMeds starter over 12 months but requires only two payments instead of four. Tirzepatide month-to-month ($289) trails OatMeds by $60/month but remains $9/month below Eden. Same flat rate at every dose; no hidden fees. Trustpilot: 4.3 stars, 79% five-star, 83% four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

Eden: All-in semaglutide rate ($198/month) within $9/month of OatMeds' no-additive plan; tirzepatide ($298/month) $69/month above OatMeds but $9 below PlexusDx. Membership and medication bundled. Verification captured July 17–23, 2026.

Peak Wellness: Semaglutide $249/month, tirzepatide $349/month. Lower rates available on six-month prepaid plans (specific figures not captured). No membership fee. Mid-pack on month-to-month billing.

Found: Cash month-to-month semaglutide $289, tirzepatide $359. Twelve-month prepaid cash plan starts from $169/month equivalent ($2,028 upfront), matching PlexusDx's three-month per-month rate but requiring full annual payment. Advertised $99/month rate is insurance-track, 12-month prepaid.

Henry Meds: Semaglutide $297/month. Tirzepatide offered only as oral dissolving tablet; no monthly injection rate captured. One subscription covers medication, shipping, provider access.

TrimRx: Checkout-verified semaglutide $299/month, tirzepatide $399/month (captured July 17–23, 2026). Advertised rates ($199 semaglutide, $349 tirzepatide) may apply to introductory periods or prepaid plans; confirm at checkout.

Embody: Semaglutide $299/month, tirzepatide $349/month. Same price at every dose; no membership. Rates unchanged from advertising to checkout (captured July 17–23, 2026).

Choose OatMeds if…

• You want the lowest verified tirzepatide month-to-month rate ($229) among the eight providers compared.
• You can pay $297–$499 upfront every 12 weeks and want the lowest 12-month total for either compound (starter semaglutide ≈ $1,287/year, starter tirzepatide ≈ $1,729/year).
• You prefer a B12 or glycine additive and are willing to start at an introductory rate that will move to the standard ongoing rate.
• You prefer no membership fee and are comfortable with quarterly renewal cycles on prepaid plans.

Choose an alternative if…

• You want lower semaglutide month-to-month costs without prepayment: PlexusDx ($189) and Eden ($198) both undercut OatMeds' $199 no-additive rate.
• You want to avoid quarterly upfront payments: PlexusDx and Found spread prepaid commitments over longer intervals (three, six, or twelve months), and PlexusDx bills semiannually on its six-month tier.
• You want verified service-quality data: PlexusDx publishes a 4.3-star Trustpilot rating with 83% of reviews four stars or higher; OatMeds review volume was insufficient for thematic capture.
• You want oral or microdose options: PlexusDx offers semaglutide and tirzepatide oral capsules and a $129/month microdose maintenance protocol; OatMeds focuses on injection.

Where PlexusDx fits

PlexusDx delivers the lowest semaglutide month-to-month rate ($189) and competitive tirzepatide pricing ($289 MTM, $249 on six-month commitment) without quarterly renewal hassles. The six-month semaglutide tier ($149/month, $1,788/year) sits $501 above OatMeds' starter plan over 12 months but requires only two payments instead of four and locks the same rate across all doses. Tirzepatide month-to-month trails OatMeds by $60/month but beats Eden by $9 and every other verified alternative by $60–$110/month. One price covers your provider visit, prescription, medication, and shipping—no membership, no hidden fees. Trustpilot: 4.3 stars, 79% five-star, 83% four stars or higher (captured September 9, 2026).

Methodology and freshness

OatMeds pricing and plan details captured September 4, 2026, from oatmeds.com. PlexusDx pricing captured September 18, 2026, from plexusdx.com. Eden, Embody, Found, Henry Meds, Peak Wellness, and TrimRx rates verified at checkout July 17–23, 2026; Found rates also re-verified July 20, 2026. Twelve-month totals, per-month equivalents for prepaid plans, and annualized costs are our calculations. We derived no figures through promotional offers or arithmetic adjustments; every published price was directly observed. Where advertised rates conflict with checkout rates, both are reported with capture dates and the conflict is noted. Review record for PlexusDx sourced from Trustpilot, captured September 9, 2026 (trustpilot.com/review/plexusdx.com). OatMeds review links retained but insufficient volume for thematic excerpts. Pricing and plan terms can change; confirm at checkout before enrolling.

Frequently Asked Questions

Is OatMeds' $99/month semaglutide rate truly $99 every month?

No. The $99 figure is a per-month equivalent of OatMeds' starter 12-week prepaid plan, which costs $297 upfront. You pay $297 every 12 weeks—four times over 12 months—for a total of approximately $1,287 per year. The ongoing month-to-month rate is $199/month ($2,388/year) with no additive, or an introductory rate of $179/month with B12 or glycine (standard ongoing rate $199/month).

Does PlexusDx beat OatMeds on semaglutide cost?

On month-to-month billing, yes: PlexusDx charges $189/month vs. OatMeds' $199/month (no additive), saving $120/year. On prepaid plans, OatMeds' starter tier (≈ $1,287/year) undercuts PlexusDx's six-month commitment ($1,788/year) by $501, but requires four quarterly payments instead of two semiannual ones.

Which provider has the lowest tirzepatide rate?

OatMeds offers the lowest verified tirzepatide month-to-month rate at $229/month ($2,748/year). Its prepaid starter plan (≈ $1,729/year) and standard plan (≈ $2,154/year) also deliver the lowest 12-month totals among the eight providers compared, though both require quarterly upfront payments.

Do OatMeds' prepaid plans renew automatically?

The evidence does not specify automatic renewal terms. Each 12-week prepaid cycle requires a new upfront payment; confirm renewal and billing mechanics at checkout or with OatMeds support before enrolling.

Are compounded semaglutide and tirzepatide FDA-approved products like Wegovy or Zepbound?

No. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. OatMeds, PlexusDx, Eden, Embody, Found, Henry Meds, Peak Wellness, and TrimRx all dispense compounded GLP-1 medications prepared by licensed compounding pharmacies, not branded FDA-approved products.

Sources

• OatMeds pricing and plan details (oatmeds.com; accessed September 4, 2026)
• PlexusDx pricing and plan details (plexusdx.com; accessed September 18, 2026)
• Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx checkout verification (July 17–23, 2026; Found re-verified July 20, 2026)
• PlexusDx Trustpilot reviews (trustpilot.com/review/plexusdx.com; accessed September 9, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.